SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Keryx Biopharmaceuticals, Inc (KERX)

KERX RSS Feed
Add KERX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/24/2016 2:03:59 AM - Followers: 137 - Board type: Free - Posts Today: 0

 

 

 

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 has demonstrated both safety and clinical efficacy in several tumor types, both as a single agent and in combination with novel therapies. KRX-0401 is currently in Phase 3 clinical development for both multiple myeloma and refractory advanced colorectal cancer, and in Phase 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 programs are being conducted under Special Protocol Assessment (SPA) agreements with the FDA. Keryx is also developing ZerenexTM (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of ZerenexTM in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is pending commencement under an SPA agreement with the FDA. Keryx also actively engages in business development activities that include seeking strategic relationships for its product candidates, as well as evaluating compounds and companies for in-licensing or acquisition.

Keryx is headquartered in New York City.

Keryx Biopharmaceuticals is traded on the Nasdaq Stock Market under the symbol "KERX."





Corporate Headquarters

 

Keryx Biopharmaceuticals, Inc.
750 Lexington Ave. - 20th Floor
New York, NY 10022
Phone: 1-212-531-5965
Fax: 1-212-531-5961
Contact Email
Investor Relations IR@keryx.com
Business Development BusDev@keryx.com
Clinical Trials ClinicalTrials@keryx.com
Employment Opportunities

Company Website
jobs@keryx.com

http://www.keryx.com/



 

Product candidate Target indication Development status
     
ZerenexTM (ferric citrate) Hyperphosphatemia in patients with end-stage renal disease U.S. Phase 3 program ongoing under SPA; 
Japan Phase 3 program ongoing by sublicensee (JT and Torii)

 

Recent News:

http://ih.advfn.com/p.php?pid=news&symbol=N%5EKERX

http://www.otcmarkets.com/stock/KERX/news  

http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-news&nyo=0

Charts:

Gallery views:

http://stockcharts.com/freecharts/gallery.html?kerx


 

                KERX - Daily Candlesticks  


Analyst's estimates and ratings: 
http://investing.money.msn.com/investments/analyst-ratings/?symbol=kerx

http://www.marketwatch.com/investing/stock/KERX/analystestimates?subview=snapshot&pg=analyst

 

The most recent Quarterly (10-Q)
 
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8450533

Do your own DD and trade smart.


 
 
  
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KERX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
KERX News: Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming October 3rd Deadline in the Class Action Law... 09/22/2016 01:07:00 PM
KERX News: Keryx Biopharmaceuticals to Webcast its Presentation at Ladenburg Thalmann’s 2016 Healthcare Conference 09/21/2016 08:30:00 AM
KERX News: GPM Reminds Investors of the October 3rd Deadline in the Class Action Lawsuit Against Keryx Pharmaceuticals, Inc. & Encourage... 09/20/2016 11:38:00 AM
KERX News: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Keryx Biopharmaceuticals, Inc. of a Class Action Lawsuit & a L... 09/19/2016 01:41:00 PM
KERX News: DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Keryx Biopharmaceuticals, Inc. Of Upcoming Deadline 09/16/2016 12:20:00 PM
PostSubject
#2959   no worries, watch what is coming! harry crumb 09/24/16 02:03:56 AM
#2958   Hope you're right. I will be happy redsox17 09/15/16 05:14:43 PM
#2957   theres no merrit for any , not 1 harry crumb 09/15/16 01:03:31 PM
#2956   kerx will b 20$ stock, giv it time, harry crumb 09/15/16 12:56:46 PM
#2955   Just playing technical bounce for now. If things rivervalley 09/08/16 11:33:20 AM
#2954   Looking good here. rivervalley 09/08/16 11:15:12 AM
#2953   Any Catalyst? Tdash 09/08/16 11:14:36 AM
#2952   Took a starter in this one this morning rivervalley 09/01/16 09:42:31 AM
#2951   It's being heavily shorted...going to be pretty volatile Asyp 08/31/16 09:37:39 PM
#2950   How low will this go? redsox17 08/31/16 03:53:57 PM
#2949   KERX bearish 4.37 stocktrademan 08/19/16 04:49:28 PM
#2948   Never claimed it was undervalued. I said it Canna_Trader 08/11/16 09:43:05 AM
#2947   How is this undervalued? They are making $9m naturalborninvestor 08/11/16 05:19:44 AM
#2946   So oversold. I'm surprised this isn't back at Canna_Trader 08/10/16 04:03:21 PM
#2945   also, these lawsuits are a joke, what exactly harry crumb 08/03/16 11:47:40 AM
#2944   great oppertunity at the bottoms here, back up harry crumb 08/03/16 11:46:08 AM
#2943   Can't believe the limited info they shared! If Tate 08/03/16 09:18:36 AM
#2942   I wonder if, considering the medical needs of fsulevine 08/03/16 08:19:20 AM
#2941   I plan to buy on this dip when fsulevine 08/03/16 08:17:18 AM
#2940   We are talking about a rubber stamp on daytona52paul 08/02/16 01:46:21 PM
#2939   daytona52paul - I wish that was the case. fsulevine 08/02/16 08:13:44 AM
#2938   Hadn't thought of that... but I kind of fsulevine 08/02/16 08:10:48 AM
#2937   Regarding the shipment to India, could the company Tate 08/01/16 06:34:03 PM
#2936   NOTHING HAS CHANGED...NOTHING. If you all read, daytona52paul 08/01/16 04:21:50 PM
#2935   I love blood..... Liquid1974 08/01/16 10:07:21 AM
#2934   Yes, this is not good news as it shadolane 08/01/16 08:16:30 AM
#2933   Ugh. Not the news I was hoping to fsulevine 08/01/16 07:55:23 AM
#2931   thats a great plan, with ya on that., harry crumb 07/20/16 04:55:26 PM
#2930   Probably yes, but I am not 100% sure fsulevine 07/19/16 02:22:05 PM
#2929   Cuppy - There are a couple paid services fsulevine 07/19/16 08:49:15 AM
#2928   Was it just you and Doug giving us Aqpham1 07/16/16 10:42:42 PM
#2927   What are "weekly script numbers"? Cuppy 07/16/16 10:45:06 AM
#2926   I hear ya! I hope we can find fsulevine 07/15/16 08:06:43 AM
#2925   Done with Yahoo. Hopefully others from the Goldboy75 07/14/16 06:50:05 PM
#2924   The new format of the Yahoo Message Boards fsulevine 07/13/16 09:17:07 AM
#2923   should move on up to 8 area before harry crumb 07/09/16 01:36:48 PM
#2922   has anyone looked at the 3 month chart? harry crumb 07/04/16 12:31:08 AM
#2921   Harry has posted Charts of the Day video thetechtrader 06/30/16 05:54:37 AM
#2920   pretty nice 3 month chart happening here. figured harry crumb 06/30/16 12:14:14 AM
#2918   insiders loading up, mayb a sale is coming, harry crumb 06/02/16 12:26:20 PM
#2917   bought 6.30-6.50 10k more harry crumb 06/02/16 12:23:54 PM
#2916   Should I buy now? redsox17 06/02/16 10:51:01 AM
#2915   right past 6.25, looking for 7.40-7.50 next level harry crumb 06/02/16 10:31:47 AM
#2914   Lots of AH action T695 06/01/16 05:50:27 PM
#2913   agree, then 8 area,, then to 10 harry crumb 05/21/16 04:54:35 PM
#2912   6.25 area will be next resistance level, break harry crumb 05/21/16 04:50:56 PM
#2911   6+ coming redsox17 05/20/16 08:17:25 PM
#2910   Yes redsox17 05/20/16 08:16:35 PM
#2909   3 month chart looking great! harry crumb 05/20/16 05:06:34 PM
#2908   Nice action today guiguich 05/02/16 03:26:42 PM
PostSubject